Alzheimer’s Disease

Emerging risk factors for preventing dementia

Clinical development of novel pharmacological treatments for Alzheimer’s disease

New approaches for developing disease modifying therapies in Alzheimer’s disease

Combination therapy for Alzheimer’s disease

Potential new symptomatic drugs for Alzheimer’s disease

The management of neuropsychiatric symptoms in Alzheimer’s disease and vascular dementia

Evaluating the effect of diabetes drug liraglutide for Alzheimer’s disease

Genetic counseling for dementia

An update on disease-modifying treatments for dementia

Ethical considerations of biomarker use in prodromal Alzheimer’s disease

The landscape of biomarkers for the management of Alzheimer’s disease

Task force from Geneva: Roadmap for biomarker validation in Alzheimer’s disease

The clinical role of MRI in dementia

Current approaches for the management of Alzheimer’s disease

Prevention strategies for Alzheimer’s disease

Imaging of Alzheimer’s disease